Literature DB >> 3136776

Modulation of urokinase-type plasminogen activator messenger RNA levels in human synovial fibroblasts by interleukin-1, retinoic acid, and a glucocorticoid.

G Vitti1, J A Hamilton.   

Abstract

Previous studies have shown that mononuclear cell-conditioned medium (MCCM), interleukin-1 (IL-1), and all-trans-retinoic acid rapidly stimulate, while glucocorticoids lower, the urokinase-type plasminogen activator (u-PA) activity of human synovial fibroblast-like cells. It is now reported that MCCM, recombinant human IL-1 alpha (rHuIL-1 alpha), rHuIL-1 beta, and all-trans-retinoic acid elevate the u-PA messenger RNA (mRNA) levels to a steady-state value within 2 hours, while dexamethasone (10(-7)M) inhibits this increase. For both situations, when the u-PA activity is either stimulated or reduced, the changes in the u-PA mRNA levels parallel the changes in the u-PA activity, and it is suggested that modulation of gene transcription plays an important role.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3136776     DOI: 10.1002/art.1780310817

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

1.  Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2.

Authors:  P H Hart; G F Vitti; D R Burgess; G A Whitty; D S Piccoli; J A Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

2.  Contrasting effects of interferon-gamma and interleukin-4 on the interleukin-6 activity of stimulated human monocytes.

Authors:  D L Cheung; P H Hart; G F Vitti; G A Whitty; J A Hamilton
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

3.  Expression of serine proteinases and metalloproteinases in organ-cultured human skin. Altered levels in the presence of retinoic acid and possible relationship to retinoid-induced loss of epidermal cohesion.

Authors:  J Varani; B Burmeister; R G Sitrin; S B Shollenberger; D R Inman; S E Fligiel; D F Gibbs; K Johnson
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

4.  Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.

Authors:  J A Hamilton; D S Piccoli; T Leizer; D M Butler; M Croatto; A K Royston
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

5.  Glucocorticoid (GC)-mediated down-regulation of urokinase plasminogen activator expression via the serum and GC regulated kinase-1/forkhead box O3a pathway.

Authors:  Travis Pew; Min Zou; Deanna R Brickley; Suzanne D Conzen
Journal:  Endocrinology       Date:  2008-01-31       Impact factor: 4.736

6.  A labile repressor acts through the NFkB-like binding sites of the human urokinase gene.

Authors:  U Novak; B G Cocks; J A Hamilton
Journal:  Nucleic Acids Res       Date:  1991-06-25       Impact factor: 16.971

7.  Suppressive effects of E3330, a novel quinone derivative, on tumor necrosis factor-alpha generation from monocytes and macrophages.

Authors:  K Miyamoto; J Nagakawa; I Hishinuma; K Hirota; M Yasuda; T Yamanaka; K Katayama; I Yamatsu
Journal:  Agents Actions       Date:  1992-11

8.  Human monocytes can produce tissue-type plasminogen activator.

Authors:  P H Hart; G F Vitti; D R Burgess; D K Singleton; J A Hamilton
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.